Helicobacter pylori infection, its laboratory diagnosis, and antimicrobial resistance: a perspective of clinical relevance

S Ansari, Y Yamaoka - Clinical microbiology reviews, 2022 - Am Soc Microbiol
Despite the recent decrease in overall prevalence of Helicobacter pylori infection, morbidity
and mortality rates associated with gastric cancer remain high. The antimicrobial resistance …

[PDF][PDF] 中国胃癌筛查与早诊早治指南(2022, 北京)

赫捷, 陈万青, 李兆申, 李霓, 任建松, 田金徽… - 中国 …, 2022 - xadxyylib.yuntsg.com
胃癌是我国常见的恶性肿瘤之一, 严重威胁我国居民生命健康. 胃癌高风险人群接受筛查和早诊
早治能够有效降低胃癌的发病率和死亡率. 制定符合中国国情的胃癌筛查与早诊早治指南 …

Gastritis: The clinico-pathological spectrum

M Rugge, E Savarino, M Sbaraglia, L Bricca… - Digestive and Liver …, 2021 - Elsevier
The inflammatory spectrum of gastric diseases includes different clinico-pathological
entities, the etiology of which was recently established in the international Kyoto …

[HTML][HTML] Management of epithelial precancerous conditions and lesions in the stomach (maps II): European Society of gastrointestinal endoscopy (ESGE), European …

P Pimentel-Nunes, D Libânio, R Marcos-Pinto… - …, 2019 - thieme-connect.com
Patients with chronic atrophic gastritis or intestinal metaplasia (IM) are at risk for gastric
adenocarcinoma. This underscores the importance of diagnosis and risk stratification for …

AGA clinical practice guidelines on management of gastric intestinal metaplasia

S Gupta, D Li, HB El Serag, P Davitkov… - …, 2020 - gastrojournal.org
AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia -
Gastroenterology Skip to Main Content Skip to Main Menu Advertisement Gastroenterology …

Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report

P Malfertheiner, F Megraud, T Rokkas, JP Gisbert… - Gut, 2022 - gut.bmj.com
Helicobacter pylori Infection is formally recognised as an infectious disease, an entity that is
now included in the International Classification of Diseases 11th Revision. This in principle …

The Colombian chemoprevention trial: 20-year follow-up of a cohort of patients with gastric precancerous lesions

MB Piazuelo, LE Bravo, RM Mera, MC Camargo… - Gastroenterology, 2021 - Elsevier
Background & Aims Helicobacter pylori eradication and endoscopic surveillance of gastric
precancerous lesions are strategies to reduce gastric cancer (GC) risk. To our knowledge …

[HTML][HTML] Treatment of Helicobacter pylori infection in atrophic gastritis

E Lahner, M Carabotti, B Annibale - World Journal of …, 2018 - ncbi.nlm.nih.gov
Helicobacter pylori (Hp) is a major human pathogen causing chronic, progressive gastric
mucosal damage and is linked to gastric atrophy and cancer. Hp-positive individuals …

Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial

JM Choi, SG Kim, J Choi, JY Park, S Oh… - Gastrointestinal …, 2018 - Elsevier
Background and Aims Whether eradication of Helicobacter pylori reduces the incidence of
metachronous gastric cancer (MGC) is still debatable. We aimed to evaluate the long-term …

Effect of Helicobacter pylori eradication therapy on the incidence of noncardia gastric adenocarcinoma in a large diverse population in the United States

D Li, SF Jiang, NY Lei, SC Shah, DA Corley - Gastroenterology, 2023 - Elsevier
Background & Aims High-quality data regarding the effect of Helicobacter pylori eradication
on the risk of noncardia gastric adenocarcinoma (NCGA) remain limited in the United States …